Contemporary Use of Oral Antithrombotic Agents: Focus on Dual and Triple Therapeutic Approaches.

@article{Jenkins2017ContemporaryUO,
  title={Contemporary Use of Oral Antithrombotic Agents: Focus on Dual and Triple Therapeutic Approaches.},
  author={Antoine T. Jenkins and Alexander Kantorovich and Luba Burman},
  journal={Pharmacotherapy},
  year={2017},
  volume={37 12},
  pages={
          1545-1564
        }
}
Atherosclerotic cardiovascular disease (ASCVD) represents a long-standing health care burden in most industrialized countries. Management of ASCVD is multifaceted, and utilization of antithrombotic agents is a key component of care to reduce vascular events. Minimizing thrombotic risk can be accomplished via antiplatelet or anticoagulant drugs; however, combination therapy is warranted for some indications. Although reducing thrombotic complications is important, it is equally vital to consider… CONTINUE READING
10
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 64 REFERENCES

Vorapaxar in patients with peripheral artery disease: results from TRA 2PTIMI

MP Bonaca, BM Scirica, MA Creager
  • Circulation
  • 2013
VIEW 8 EXCERPTS
HIGHLY INFLUENTIAL

Apixaban with antiplatelet therapy after acute coronary syndrome.

  • The New England journal of medicine
  • 2011
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL